1Rischin D, Narayan K, Oza AM, et al. Phase I study tff tir- apazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer [ J ] .Int J Gynecol Cancer ,2010,20(5 ) : 827.
2Li HX,Zhang S,Lei DS,et al. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non- small cell lung cancer[J]. Oncol Rep,2005,13( 1 ) : 145.
3Zhang J,Jia Q,Zou S,et al. Thymidine kinase l :a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients [ J ]. Oncol Rep, 2006, 15 (2) : 455.
5Amer ES, Spasokoukotskaja T, Eriksson S. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues[J]. Biochem Biophys Res Commun,1992, 88 (2) : 712 -718.
6Zhang F, Li H, Pendleton AR, et al. Thymidine kinase 1 immunoassay:a potential marker for breast cancer [J]. Cancer Detect Prey ,2001 ,25 ( 1 ) :8 - 15.
7Zhang J, Jia Q, Zou S,et al. Thymidine kinase 1 : a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients [ J ]. Oncol Rep, 2006, 15(2) : 455 -461.
